52 results
DEF 14C
BGLC
BioNexus Gene Lab Corp
29 Feb 24
Information statement
5:16pm
of, our independent auditor and engages such independent auditor;
Approves the plan and fees for the annual audit, quarterly reviews, tax and other … , 2023 and 2022 totaled $5,200 and $2,301, respectively.
Tax Fees. The aggregate fees billed by the Auditor for professional services were rendered
PRE 14C
BGLC
BioNexus Gene Lab Corp
26 Jan 24
Preliminary information
4:05pm
of, our independent auditor and engages such independent auditor;
Approves the plan and fees for the annual audit, quarterly reviews, tax and other audit … , 2023 and 2022 totaled $5,200 and $2,301, respectively.
Tax Fees. The aggregate fees billed by the Auditor for professional services were rendered
8-K
EX-1.1
p1bgw90lbdb7ud7subc
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
8-K
EX-4.1
8etwc43
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
424B4
2btpd nznm
21 Jul 23
Prospectus supplement with pricing info
3:37pm